论文部分内容阅读
将１５６例慢性非细菌性前列腺炎和前列腺痛病人随机分为三组，①Ａ组５１例，年龄２８±８岁，给予泌尿灵４００ｍｇ，２次／ｄ；②Ｂ组４９例，年龄２７±１０岁，给予非普拉宗２００ｍｇ，２次／ｄ；③Ｃ组５６例，年龄３０±７岁，给予泌尿灵４００ｍｇ加非普拉宗２００ｍｇ，２次／ｄ。结果示，Ｃ组总有效率８３．９％，与Ａ组（６４．７％）和Ｂ组（６１．３％）比较，差异显著（Ｐ＜０．０５，Ｐ＜０．０１）。Ａ组在改善尿流率指标方面比Ｂ组好，但Ｂ组解除临床症状比Ａ组好，Ｃ组在改善尿流率指标和解除临床症状方面均优于Ａ与Ｂ组。
A total of 156 patients with chronic nonbacterial prostatitis and prostatic pain were randomly divided into three groups: ①A group of 51 patients, aged 28 ± 8 years old, given 400mg urinary tract, 2 times / d; ②B group 49 patients, aged 27 ± 10 years , Given non-Pulazan 200mg, 2 times / d; ③ C group of 56 patients, aged 30 ± 7 years old, given urinary 400mg plus non-Pulazan 200mg, 2 times / d. The results showed that the total effective rate of group C was 83.9%, which was significantly different from that of group A (64.7%) and group B (61.3%) (P <0.05, P <0.01). The improvement of urinary flow rate in group A was better than that in group B, but the clinical symptoms in group B were better than that in group A, and group C was superior to group A and B in improving the index of urinary flow rate and relieving the clinical symptoms.